Cardiologists from NYU Langone Heart are showcasing their latest clinical findings and research discoveries during the 2025 ...

Around 35 French higher education institutions, coordinated by Campus France, are participating in the 2025 Asia-Pacific ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...

First Analysis from Phase 1b Study of GT-02287 in Parkinson’s Disease Expected in Q2 2025BETHESDA, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the ...

International non-profit organization The Global Alzheimer’s Platform Foundation ® (GAP) in collaboration with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) and ...

RRCAT continues to advance in accelerator technologies, including free electron lasers (FEL) in terahertz (THz) and infrared ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...

More than 900 students from throughout Florida took part in the 70th Annual State Science and Engineering Fair of Florida, ...

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, today announced it will present preclinical ...